(Date:12/14/2009)... 14 Dyadic International, Inc. (Pink Sheets: ... its collaboration with The Scripps Research Institute ("Scripps") ... re-annotate the genome of Dyadic,s patented and proprietary ... continuation of the successful relationship between the two ... engaged Scripps to annotate the C1 genome for ...
(Date:12/14/2009)... Boston Scientific Corporation (NYSE: BSX ... of $2 billion aggregate principal amount of its senior ... public offering consists of $850 million of 4.50 percent ... notes due January 2020 and $300 million of 7.375 ... to use the net proceeds for general corporate purposes, ...
(Date:12/14/2009)... Mass., Dec. 14 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that, owing ... atrial fibrillation drug market will increase more than ... billion in 2018 in the United States, France, ... ,, The new Pharmacor report entitled Atrial ...
(Date:12/11/2009)... ROCKVILLE, Md., Dec. 11 EntreMed, Inc. ... of $1.7 million in royalty revenue from sales ... estimated royalty revenue of $3.3 million. In ... quarter and projected revenue for fiscal 2009. ... the third quarter will be reflected in the ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2EntreMed Reports Receipt of Third Quarter Royalty Payment 2... market is poised to exceed $539 million by 2012. Consumables, life ... areas that are expected to drive the industry,s growth in the ... ... 10, 2008 -- Economic trends, mergers & acquisitions in the industry, ...
... and LOS ANGELES, November 10 , - Current ... - Residual Risk Reduction Initiative (R3i) Calls for Action ... Standards,of Care in Millions of Patients With Heart Disease ... Europe, Asia,and Japan have come together today to launch ...
... and research group Plasma & Materials Processing (PMP) of ... awarded the Leverhulme Technology Transfer Award 2008. They receive ... for the research group) for their successful transfer of ... Hoex,s Ph.D. research was rewarded with the SolarWorld Junior ...
Other Biology Technology:Calorimeters and Thermal Analysis Equipment Market to Exceed $539 Million by 2012, According to New Report by Global Industry Analysts 2Calorimeters and Thermal Analysis Equipment Market to Exceed $539 Million by 2012, According to New Report by Global Industry Analysts 3Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today 2Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today 3TU/e awarded for knowledge transfer to solar energy industry 2Mouse monoclonal [002-49] to C1s ( Abpromise for all tested applications). entrezGeneID: 716 SwissProtID: P09871...
Rabbit polyclonal to Oct2, prediluted ( Abpromise for all tested applications). entrezGeneID: 5452 SwissProtID: P09086...
Selenoprotein P Purified Anti-Mouse clone 35, Isotype Mouse IgG 2b , 50 µg Consult technical datasheet for details....
Oct 2 Immunogen: Full length human protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products:Biology NavigationMedical Navigation